Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GnRHa Risk Model for Depression in Healthy Women
NCT02661789Completed
- Start
- Jan 2011
- Primary completion
- Dec 2012
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial comparing GnRHa Arm with Placebo Arm (2 arms). Primary endpoints: Changes from baseline in symptoms of depression at 16 days, Changes from baseline in serotonin transporter binding in volumes of interest (VOIs) at 16 days and 13 more. Started Jan 2011; status: completed.
02
Drugs
goserelin
Beyond the preview
Go deeper on NCT02661789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02661789.